Proficio Capital Partners LLC acquired a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 2,381 shares of the conglomerate’s stock, valued at approximately $454,000.
A number of other institutional investors have also recently modified their holdings of the stock. EP Wealth Advisors LLC acquired a new stake in Danaher during the second quarter worth about $3,807,000. Northwestern Mutual Wealth Management Co. raised its position in Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares in the last quarter. Puzo Michael J bought a new stake in shares of Danaher during the 2nd quarter worth $8,624,000. Legal & General Group Plc lifted its holdings in shares of Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after acquiring an additional 43,169 shares during the last quarter. Finally, Madison Asset Management LLC bought a new position in Danaher in the 2nd quarter valued at approximately $85,451,000. 79.05% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of brokerages recently issued reports on DHR. Wells Fargo & Company dropped their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. Citigroup started coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. HSBC cut their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Royal Bank Of Canada lifted their target price on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Finally, Evercore reissued an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $228.91.
Danaher Trading Up 0.2%
DHR opened at $215.74 on Friday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a market cap of $151.67 billion, a P/E ratio of 38.32, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. The company has a fifty day moving average price of $198.69 and a two-hundred day moving average price of $192.35.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 EPS. Analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
